StreetInsider.com News Articles

Overseas Shipholding Group (OSG) Tops Q1 EPS by 30c

Wed, 06 May 2026 17:22:40 -0400

Overseas Shipholding Group (NYSE: OSG) reported Q1 EPS of $0.37, $0.30 better than the analyst estimate of $0.07. Revenue for the quarter came in at $104.17 million versus the consensus estimate of $16.3 million.

For earnings history and earnings-related data on Overseas Shipholding Group (OSG) click here.

Octave Specialty Group Reports First Quarter 2026 Results

Wed, 06 May 2026 16:35:00 -0400

Total P&C premium production increased 66% for the quarter to $531 million
Insurance Distribution Segment
- Total revenue grew 92% to $79 million, including the impact of the October 2025 acquisition of ArmadaCare
- Organic revenue growth equaled 42%
- Net income to Shareholders of $13 million, compared to net loss of $(3) million in 1Q25
- Adjusted EBITDA to Shareholders of $25 million, compared to $7 million in 1Q25
- Pre-tax income and Adjusted EBITDA margin to shareholders reached 16% and 32%, respectively
Specialty P&C Insurance Segment ("Everspan")
- Gross and net premiums written of $104 million and $32 million were up 19% and 80%, respectively
- Net loss was $(8) million,

Octave Specialty Group Reports First Quarter 2026 Results

Wed, 06 May 2026 16:35:00 -0400

Total P&C premium production increased 66% for the quarter to $531 million

Insurance Distribution Segment

Total revenue grew 92% to $79 million, including the impact of the October 2025 acquisition of ArmadaCare

Organic revenue growth equaled 42%

Net income to Shareholders of $13 million, compared to net loss of $(3) million in 1Q25

Adjusted EBITDA to Shareholders of $25 million, compared to $7 million in 1Q25

Pre-tax income and Adjusted EBITDA margin to shareholders reached 16% and 32%, respectively

Specialty P&C Insurance Segment ("Everspan")

Gross and net premiums written of $104 million and $32 million were up 19% and 80%, respectively

Net loss was $(8) million,

Octave Specialty Group Reports First Quarter 2026 Results

Wed, 06 May 2026 16:35:00 -0400

Total P&C premium production increased 66% for the quarter to $531 million

Insurance Distribution Segment

Total revenue grew 92% to $79 million, including the impact of the October 2025 acquisition of ArmadaCare

Organic revenue growth equaled 42%

Net income to Shareholders of $13 million, compared to net loss of $(3) million in 1Q25

Adjusted EBITDA to Shareholders of $25 million, compared to $7 million in 1Q25

Pre-tax income and Adjusted EBITDA margin to shareholders reached 16% and 32%, respectively

Specialty P&C Insurance Segment ("Everspan")

Gross and net premiums written of $104 million and $32 million were up 19% and 80%, respectively

Net loss was $(8) million,

Octave Specialty Group Reports First Quarter 2026 Results

Wed, 06 May 2026 16:35:00 -0400

Total P&C premium production increased 66% for the quarter to $531 million

Insurance Distribution Segment

Total revenue grew 92% to $79 million, including the impact of the October 2025 acquisition of ArmadaCare

Organic revenue growth equaled 42%

Net income to Shareholders of $13 million, compared to net loss of $(3) million in 1Q25

Adjusted EBITDA to Shareholders of $25 million, compared to $7 million in 1Q25

Pre-tax income and Adjusted EBITDA margin to shareholders reached 16% and 32%, respectively

Specialty P&C Insurance Segment ("Everspan")

Gross and net premiums written of $104 million and $32 million were up 19% and 80%, respectively

Net loss was $(8) million,

Octave Specialty Group to Release First Quarter 2026 Results on May 6, 2026

Thu, 09 Apr 2026 16:19:00 -0400

Conference Call Scheduled for May 7, 2026

NEW YORK--(BUSINESS WIRE)-- Octave Specialty Group, Inc. (NYSE: OSG), a global specialty insurance firm, will release first quarter 2026 results on May 6, 2026, following the close of the market.
Conference Call
On May 7, 2026, at 8:30am (ET), Claude LeBlanc, President and Chief Executive Officer, and David Trick, Executive Vice President and Chief Financial Officer, will discuss first quarter 2026 results during a live conference call. A live audio webcast of the call will be available through the Investor Relations section of Octave’s website, www.octavegroup.com. Participants may

Octave Specialty Group to Release First Quarter 2026 Results on May 6, 2026

Thu, 09 Apr 2026 16:19:00 -0400

Conference Call Scheduled for May 7, 2026

NEW YORK--(BUSINESS WIRE)-- Octave Specialty Group, Inc. (NYSE: OSG), a global specialty insurance firm, will release first quarter 2026 results on May 6, 2026, following the close of the market.
Conference Call
On May 7, 2026, at 8:30am (ET), Claude LeBlanc, President and Chief Executive Officer, and David Trick, Executive Vice President and Chief Financial Officer, will discuss first quarter 2026 results during a live conference call. A live audio webcast of the call will be available through the Investor Relations section of Octave’s website, www.octavegroup.com. Participants may

Octave Specialty Group to Release First Quarter 2026 Results on May 6, 2026

Thu, 09 Apr 2026 16:19:00 -0400

Conference Call Scheduled for May 7, 2026

NEW YORK--(BUSINESS WIRE)-- Octave Specialty Group, Inc. (NYSE: OSG), a global specialty insurance firm, will release first quarter 2026 results on May 6, 2026, following the close of the market.
Conference Call
On May 7, 2026, at 8:30am (ET), Claude LeBlanc, President and Chief Executive Officer, and David Trick, Executive Vice President and Chief Financial Officer, will discuss first quarter 2026 results during a live conference call. A live audio webcast of the call will be available through the Investor Relations section of Octave’s website, www.octavegroup.com. Participants may

Octave Specialty Group to Release First Quarter 2026 Results on May 6, 2026

Thu, 09 Apr 2026 16:19:00 -0400

Conference Call Scheduled for May 7, 2026

NEW YORK--(BUSINESS WIRE)-- Octave Specialty Group, Inc. (NYSE: OSG), a global specialty insurance firm, will release first quarter 2026 results on May 6, 2026, following the close of the market.
Conference Call
On May 7, 2026, at 8:30am (ET), Claude LeBlanc, President and Chief Executive Officer, and David Trick, Executive Vice President and Chief Financial Officer, will discuss first quarter 2026 results during a live conference call. A live audio webcast of the call will be available through the Investor Relations section of Octave’s website, www.octavegroup.com. Participants may

Octave Specialty Group Announces Meeting and Record Date for 2026 Annual Meeting of Stockholders

Mon, 23 Mar 2026 08:30:00 -0400

NEW YORK--(BUSINESS WIRE)-- Octave Specialty Group, Inc. (NYSE: OSG), a global specialty insurance firm, today announced that Octave’s 2026 Annual Meeting of Stockholders will be held on Thursday, May 28, 2026, at 11 a.m. (ET). The meeting will be held in a virtual format. The record date for determining stockholders entitled to notice of, and to vote at, the annual meeting will be the close of business on April 2, 2026.
Further information regarding the Annual Meeting will be set forth in the proxy statement and other proxy materials for the Annual Meeting.
About Octave
Octave Specialty Group, Inc. is

Octave Specialty Group Announces Meeting and Record Date for 2026 Annual Meeting of Stockholders

Mon, 23 Mar 2026 08:30:00 -0400

NEW YORK--(BUSINESS WIRE)-- Octave Specialty Group, Inc. (NYSE: OSG), a global specialty insurance firm, today announced that Octave’s 2026 Annual Meeting of Stockholders will be held on Thursday, May 28, 2026, at 11 a.m. (ET). The meeting will be held in a virtual format. The record date for determining stockholders entitled to notice of, and to vote at, the annual meeting will be the close of business on April 2, 2026.
Further information regarding the Annual Meeting will be set forth in the proxy statement and other proxy materials for the Annual Meeting.
About Octave
Octave Specialty Group, Inc. is

Octave Specialty Group Announces Meeting and Record Date for 2026 Annual Meeting of Stockholders

Mon, 23 Mar 2026 08:30:00 -0400

NEW YORK--(BUSINESS WIRE)-- Octave Specialty Group, Inc. (NYSE: OSG), a global specialty insurance firm, today announced that Octave’s 2026 Annual Meeting of Stockholders will be held on Thursday, May 28, 2026, at 11 a.m. (ET). The meeting will be held in a virtual format. The record date for determining stockholders entitled to notice of, and to vote at, the annual meeting will be the close of business on April 2, 2026.
Further information regarding the Annual Meeting will be set forth in the proxy statement and other proxy materials for the Annual Meeting.
About Octave
Octave Specialty Group, Inc. is

Octave Specialty Group Announces Meeting and Record Date for 2026 Annual Meeting of Stockholders

Mon, 23 Mar 2026 08:30:00 -0400

NEW YORK--(BUSINESS WIRE)-- Octave Specialty Group, Inc. (NYSE: OSG), a global specialty insurance firm, today announced that Octave’s 2026 Annual Meeting of Stockholders will be held on Thursday, May 28, 2026, at 11 a.m. (ET). The meeting will be held in a virtual format. The record date for determining stockholders entitled to notice of, and to vote at, the annual meeting will be the close of business on April 2, 2026.
Further information regarding the Annual Meeting will be set forth in the proxy statement and other proxy materials for the Annual Meeting.
About Octave
Octave Specialty Group, Inc. is

Overseas Shipholding Group (OSG) PT Lowered to $12 at Truist Securities

Wed, 25 Feb 2026 09:44:10 -0400
Truist Securities analyst Mark Hughes lowered the price target on Overseas Shipholding Group (NYSE: OSG) to $12.00 (from $15.00) while maintaining a rating.

Overseas Shipholding Group (OSG) Tops Q4 EPS by 13c

Mon, 23 Feb 2026 16:23:43 -0400

Overseas Shipholding Group (NYSE: OSG) reported Q4 EPS of ($0.02), $0.13 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $66.9 million versus the consensus estimate of $27.46 million.
For earnings history and earnings-related data on Overseas Shipholding Group (OSG) click here.

Octave Specialty Group Reports Fourth Quarter 2025 Results

Mon, 23 Feb 2026 16:05:00 -0400

Total P&C premium production increased 15% for the quarter to $303 million

Insurance Distribution Segment

Commission Income grew to $37 million, an increase of 13%

Organic revenue growth equaled 8.1%

Net loss to Shareholders of $(1) million for the quarter, an improvement of 76%

Adjusted EBITDA to Shareholders of $7 million for the quarter, up 33%

Specialty P&C Insurance ("Everspan")

Gross and net premiums written of $80 million and $23 million were up 34% and 978%, respectively

Combined ratio fell below 100%

Net income to Shareholders was $1 million, down 37%

Adjusted EBITDA to Shareholders of $1.5 million, down 46%

NEW YORK--(BUSINESS WIRE)-- Octave Specialty

Octave Specialty Group Reports Fourth Quarter 2025 Results

Mon, 23 Feb 2026 16:05:00 -0400

Total P&C premium production increased 15% for the quarter to $303 million

Insurance Distribution Segment

Commission Income grew to $37 million, an increase of 13%

Organic revenue growth equaled 8.1%

Net loss to Shareholders of $(1) million for the quarter, an improvement of 76%

Adjusted EBITDA to Shareholders of $7 million for the quarter, up 33%

Specialty P&C Insurance ("Everspan")

Gross and net premiums written of $80 million and $23 million were up 34% and 978%, respectively

Combined ratio fell below 100%

Net income to Shareholders was $1 million, down 37%

Adjusted EBITDA to Shareholders of $1.5 million, down 46%

NEW YORK--(BUSINESS WIRE)-- Octave Specialty

Octave Specialty Group Reports Fourth Quarter 2025 Results

Mon, 23 Feb 2026 16:05:00 -0400

Total P&C premium production increased 15% for the quarter to $303 million

Insurance Distribution Segment

Commission Income grew to $37 million, an increase of 13%

Organic revenue growth equaled 8.1%

Net loss to Shareholders of $(1) million for the quarter, an improvement of 76%

Adjusted EBITDA to Shareholders of $7 million for the quarter, up 33%

Specialty P&C Insurance ("Everspan")

Gross and net premiums written of $80 million and $23 million were up 34% and 978%, respectively

Combined ratio fell below 100%

Net income to Shareholders was $1 million, down 37%

Adjusted EBITDA to Shareholders of $1.5 million, down 46%

NEW YORK--(BUSINESS WIRE)-- Octave Specialty

Octave Specialty Group Reports Fourth Quarter 2025 Results

Mon, 23 Feb 2026 16:05:00 -0400

Total P&C premium production increased 15% for the quarter to $303 million

Insurance Distribution Segment

Commission Income grew to $37 million, an increase of 13%

Organic revenue growth equaled 8.1%

Net loss to Shareholders of $(1) million for the quarter, an improvement of 76%

Adjusted EBITDA to Shareholders of $7 million for the quarter, up 33%

Specialty P&C Insurance ("Everspan")

Gross and net premiums written of $80 million and $23 million were up 34% and 978%, respectively

Combined ratio fell below 100%

Net income to Shareholders was $1 million, down 37%

Adjusted EBITDA to Shareholders of $1.5 million, down 46%

NEW YORK--(BUSINESS WIRE)-- Octave Specialty

Hammurabi, a Division of Xchange Benefits, Unveils AI Platform That Revolutionizes Medical Stop Loss Underwriting

Wed, 18 Feb 2026 08:30:00 -0400

ARMONK, N.Y.--(BUSINESS WIRE)-- Hammurabi, a division of accident and health managing general underwriter Xchange Benefits LLC, a subsidiary of Octave Specialty Group, Inc. (NYSE: OSG), has unveiled an artificial intelligence platform that fundamentally transforms how medical stop loss insurance is underwritten, replacing a traditionally labor-intensive process with near-instant risk prediction and pricing accuracy.
Designed to deliver efficiencies in the $40 billion medical stop loss market, Hammurabi’s proprietary neuro-semiotic models apply advanced machine learning to predict employer health risk with speed and precision. The result is a dramatic reduction in standard market underwriting timelines—from days to minutes—while delivering accurate

Hammurabi, a Division of Xchange Benefits, Unveils AI Platform That Revolutionizes Medical Stop Loss Underwriting

Wed, 18 Feb 2026 08:30:00 -0400

ARMONK, N.Y.--(BUSINESS WIRE)-- Hammurabi, a division of accident and health managing general underwriter Xchange Benefits LLC, a subsidiary of Octave Specialty Group, Inc. (NYSE: OSG), has unveiled an artificial intelligence platform that fundamentally transforms how medical stop loss insurance is underwritten, replacing a traditionally labor-intensive process with near-instant risk prediction and pricing accuracy.
Designed to deliver efficiencies in the $40 billion medical stop loss market, Hammurabi’s proprietary neuro-semiotic models apply advanced machine learning to predict employer health risk with speed and precision. The result is a dramatic reduction in standard market underwriting timelines—from days to minutes—while delivering accurate

Hammurabi, a Division of Xchange Benefits, Unveils AI Platform That Revolutionizes Medical Stop Loss Underwriting

Wed, 18 Feb 2026 08:30:00 -0400

ARMONK, N.Y.--(BUSINESS WIRE)-- Hammurabi, a division of accident and health managing general underwriter Xchange Benefits LLC, a subsidiary of Octave Specialty Group, Inc. (NYSE: OSG), has unveiled an artificial intelligence platform that fundamentally transforms how medical stop loss insurance is underwritten, replacing a traditionally labor-intensive process with near-instant risk prediction and pricing accuracy.
Designed to deliver efficiencies in the $40 billion medical stop loss market, Hammurabi’s proprietary neuro-semiotic models apply advanced machine learning to predict employer health risk with speed and precision. The result is a dramatic reduction in standard market underwriting timelines—from days to minutes—while delivering accurate

Hammurabi, a Division of Xchange Benefits, Unveils AI Platform That Revolutionizes Medical Stop Loss Underwriting

Wed, 18 Feb 2026 08:30:00 -0400

ARMONK, N.Y.--(BUSINESS WIRE)-- Hammurabi, a division of accident and health managing general underwriter Xchange Benefits LLC, a subsidiary of Octave Specialty Group, Inc. (NYSE: OSG), has unveiled an artificial intelligence platform that fundamentally transforms how medical stop loss insurance is underwritten, replacing a traditionally labor-intensive process with near-instant risk prediction and pricing accuracy.
Designed to deliver efficiencies in the $40 billion medical stop loss market, Hammurabi’s proprietary neuro-semiotic models apply advanced machine learning to predict employer health risk with speed and precision. The result is a dramatic reduction in standard market underwriting timelines—from days to minutes—while delivering accurate

Hammurabi, a Division of Xchange Benefits, Unveils AI Platform That Revolutionizes Medical Stop Loss Underwriting

Wed, 18 Feb 2026 08:30:00 -0400

ARMONK, N.Y.--(BUSINESS WIRE)-- Hammurabi, a division of accident and health managing general underwriter Xchange Benefits LLC, a subsidiary of Octave Specialty Group, Inc. (NYSE: OSG), has unveiled an artificial intelligence platform that fundamentally transforms how medical stop loss insurance is underwritten, replacing a traditionally labor-intensive process with near-instant risk prediction and pricing accuracy.
Designed to deliver efficiencies in the $40 billion medical stop loss market, Hammurabi’s proprietary neuro-semiotic models apply advanced machine learning to predict employer health risk with speed and precision. The result is a dramatic reduction in standard market underwriting timelines—from days to minutes—while delivering accurate

Hammurabi, a Division of Xchange Benefits, Unveils AI Platform That Revolutionizes Medical Stop Loss Underwriting

Wed, 18 Feb 2026 08:30:00 -0400

ARMONK, N.Y.--(BUSINESS WIRE)-- Hammurabi, a division of accident and health managing general underwriter Xchange Benefits LLC, a subsidiary of Octave Specialty Group, Inc. (NYSE: OSG), has unveiled an artificial intelligence platform that fundamentally transforms how medical stop loss insurance is underwritten, replacing a traditionally labor-intensive process with near-instant risk prediction and pricing accuracy.
Designed to deliver efficiencies in the $40 billion medical stop loss market, Hammurabi’s proprietary neuro-semiotic models apply advanced machine learning to predict employer health risk with speed and precision. The result is a dramatic reduction in standard market underwriting timelines—from days to minutes—while delivering accurate